Address And Details

8730 Stony Point Parkway, Suite 205 , Richmond, VA 23235
Fund Manager Kevin Miller
Manager Tenure 5 Years 3 Months

Strategy And Objective

The E-Valuator Aggressive Growth (85%-99%) RMS (Risk-Managed Strategy) Fund (the Fund seeks to provide growth of principal within the stated asset allocation range. The Fund seeks to achieve its objective by investing, under normal market conditions, in the securities of other unaffiliated investment companies, including open-end funds, exchange-traded funds ( ETFs ) and closed-end funds (collectively referred to as Underlying Funds. The Fund utilizes a risk-managed strategy (thus, the term RMS in the Fund s name), which involves the allocation of invested assets across multiple underlying investments in a manner that attempts to limit fluctuations in annualized returns that would be commensurate to an investor seeking to experience very low volatility as measured by standard deviation. An investments volatility is commonly measured by standard deviation. Standard deviation provides the probable range of anticipated returns based on the performance fluctuations over previous time periods (1-year, 3-year, or 5-year).Investments with the lowest levels of standard deviation would be considered very conservative (less volatile), while investments with higher levels of standard deviation would be considered more growth oriented and aggressive in nature (more volatile). The strategy of this Fund is to keep the level of annualized performance fluctuation within standard deviation parameters that would be suitable for an aggressive growth oriented investor, therefore being the most volatile investment of the funds within the family of funds comprising the E-Valuator Funds. The standard deviation goal forth Fund is to average between 9.5% to 13.5% over a 3-year time frame or a 5-year time frame. The Fund allocates assets across three broad asset classes (money market, bonds, equities) in a manner that provides a high probability of meeting the accepted standard deviation goals. The Fund will generally allocate 1%-15% of its assets into a variety of Underlying Funds that focus on investments in fixed income securities ( e.g. ., money markets and bonds) that possess varying qualities of credit and duration including high-yield securities (also referred to as junk bonds). The remaining 85%-99% of the Funds assets will generally be allocated to equity securities that have the potential of providing dividends and growth on an annual basis. The equity allocation will be invested in Underlying Funds that invest in U.S. and foreign securities (including emerging markets securities) and that focus on investments without regard to market capitalization (i.e., investments may include securities of issuers that would be considered small, medium and/or large capitalization companies).The Fund identifies an emerging market security based on it being placed in the Diversified Emerging Market equity category by Morning star, Inc.

Net Asset Value

as of 7:14 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.74%
  • 1 Month
  • +0.34%
  • 3 Months
  • +1.50%
  • 1 Yr Return
  • n/a
  • 5 Yr Return
  • n/a

Equity Sector Breakdown

Finance 93.10%
ConsumerDurables n/a
Energy n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 95.58%
Stocks 4.42%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 14.10 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -5.52 -3.72 n/a
Beta 0.97 0.92 n/a
R Squared 0.93 0.81 n/a
Std Deviation 18.73 15.44 n/a
Sharpe Ratio 0.63 0.79 n/a

Purchase Information

as of 6:39 PM ET 09/16/2021
Minimum Initial $10000
Minimum Additional $100
Minimum Initial IRA $10000

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +24.03%
  • +35.63%
+24.03% +35.63%
3 Year
  • +11.04%
  • +11.86%
+11.04% +11.86%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +12.53%
  • +12.52%
+12.53% +12.52%

Top 10 Holdings

Symbol Company Name % Of Assets
SWPPX SCHWAB S&P 500 FUND 5.43%
SCHD SCHWAB US DIVIDEND EQUITY 5.33%
SCHG SCHWAB US LARGE CAP GR ETF 4.63%
VWIGX VANGUARD INTERNATIONAL GR 3.40%
JVAL JPMORGAN US VALUE FACTOR ETF 3.29%
VLU SPDR S&P 1500 VALUE TILT ETF 3.29%
HFLYX HARTFORD FLOATING RATE FD C Y 3.07%
SPDW SPDR PTF DEV WORLD EX-US ETF 2.98%
VV VANGUARD LARGE CAP VIPERS 2.93%
FPMIX FIDELITY EMERG MKT INDEX FUND 2.81%

Recent Articles from TheStreet

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.

Evergrande Group Lead

China Faces 'Lehman Moment' With Evergrande Collapse, So What Are The Risks?

'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.